» Authors » Isabel Martin-Garrido

Isabel Martin-Garrido

Explore the profile of Isabel Martin-Garrido including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-de-Las-Penas C, Franco-Moreno A, Ruiz-Ruigomez M, Arrieta-Ortubay E, Ryan-Murua P, Lumbreras-Bermejo C, et al.
Viruses . 2024 Jun; 16(6). PMID: 38932239
The aim of this study was to investigate the effects of administrating Remdesivir at the acute COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 survivors by controlling factors...
2.
Dorronzoro-Zubiete E, Castro-Marrero J, Ropero J, Sevillano-Ramos J, Hernandez M, Sanmartin Sentanes R, et al.
JMIR Res Protoc . 2024 Apr; 13:e50157. PMID: 38608263
Background: Fatigue is the most common symptom in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID, impacting patients' quality of life; however, there is currently a lack of evidence-based context-aware...
3.
Guisado-Vasco P, Silva M, Duarte-Millan M, Sambataro G, Bertolazzi C, Pavone M, et al.
PLoS One . 2019 Nov; 14(11):e0224772. PMID: 31703067
Background: Interstitial lung disease (ILD) is a frequent manifestation of Sjögren's syndrome (SS), an autoimmune disease of salivary and lacrimal glands, and affects approximately 20% of patients. No clinical or...
4.
Calero-Bernal M, Martin-Garrido I, Donazar-Ezcurra M, Limper A, Carmona E
Can Respir J . 2016 Oct; 2016:2464791. PMID: 27721666
. pneumonia (PCP) is rising in the non-HIV population and associates with higher morbidity and mortality. The aggressive immunosuppressive regimens, as well as the lack of stablished guidelines for chemoprophylaxis,...
5.
Boixeda R, Almagro P, Diez-Manglano J, Cabrera F, Recio J, Martin-Garrido I, et al.
Int J Chron Obstruct Pulmon Dis . 2015 Dec; 10:2581-91. PMID: 26664106
Objective: To determine in patients admitted with an acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) the association between the isolation of potential pathogens in a conventional sputum culture and...
6.
Martin-Garrido I, Carmona E, Specks U, Limper A
Chest . 2012 Dec; 144(1):258-265. PMID: 23258406
Background: Pneumocystis pneumonia (PcP) is an opportunistic fungal infection. Although T-cell immunity is classically related to Pneumocystis defense, recent data support roles for B lymphocytes in the development of PcP...
7.
Wissmann G, Morilla R, Martin-Garrido I, Friaza V, Respaldiza N, Povedano J, et al.
Eur J Clin Invest . 2011 Feb; 41(3):343-8. PMID: 21299548
Background: Infliximab, a chimeric antitumour necrosis factor (TNF) monoclonal antibody, has become an established effective therapy for inflammatory rheumatic disease. However, TNF is a critical factor in host defence, and...
8.
Gutierrez S, Morilla R, Leon J, Martin-Garrido I, Rivero L, Friaza V, et al.
J Adolesc Health . 2010 Dec; 48(1):103-5. PMID: 21185532
Background: Pneumocystis colonization in young HIV-infected patients has been poorly studied. The aim of this study was to analyze the prevalence of P jiroveci colonization in a cohort of young...
9.
Atienza M, Respaldiza N, Santa E, Martin-Garrido I, Medrano F, Varela J, et al.
Scand J Infect Dis . 2008 Jul; 40(10):840-2. PMID: 18609205
It is well documented that antiphospholipid antibodies are increased in patients with HIV-1 infection and these are most commonly seen in those with Pneumocystis jirovecii pneumonia. Therefore it has been...